Login / Signup

The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy.

Yi-Sin WongSheng-Feng SungChi-Shun WuYung-Chu HsuYu-Hsiang SuLing-Chien HungCheung-Ter Ong
Published in: Drug design, development and therapy (2020)
In severe and very severe stroke patients receiving low-dose tPA thrombolytic therapy, a bolus dose of 15% of the total dose can improve outcomes.
Keyphrases
  • low dose
  • atrial fibrillation
  • pulmonary embolism
  • high dose
  • early onset
  • type diabetes
  • stem cells
  • weight loss
  • glycemic control